Chimeric antigen receptor (CAR) T cells are genetically modified cell therapy products targeted to kill tumor cells. Their development and manufacturing require stringent quality control assessments at every workflow step. Researchers tackle these challenges using cutting-edge technologies to bring top-notch products to clinics.
Download this ebook from Bio-Rad to learn about key devices that facilitate high-quality cell therapy product development.
Top Image Credit:
A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.
View this Issue
In this webinar, Ethan Shelkey and Aurita Menezes will highlight key aspects in the design of cell-based assays.
Discover how alternative animal models provide new perspectives on physiological and biochemical processes.
Experts from the Women’s Brain Foundation and bit.bio will explore the importance of sex-specific in vitro models for neurological research and drug discovery.
Discover how scientists are designing the next groundbreaking vaccines against infectious diseases.
Multiomics platform streamlines workflows and provides real-time insights, optimizing resource usage and ensuring smooth, data-driven operations
Learn how to overcome the challenges of viral transduction workflows.
Inventia Life Science, an innovator in 3D cell culture technologies, announces the launch of RASTRUM™ Allegro, a groundbreaking advancement in 3D cell culture technology designed to accelerate drug discovery and disease research with unprecedented scalability, reproducibility, and efficiency.
Learn how a target enrichment approach improves the discovery and characterization of viral pathogens.
